[1] |
GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global,regional,and national morbidity,mortality,and etiologies of lower respiratory infections in 195 countries,1990-2016:a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet Infect Dis, 2018, 18(11):1191-1210.
DOI
URL
|
[2] |
ESCRIBANO MONTANER A, GARCÍA DE LOMAS J, VILLA ASENSI J R, et al. Bacteria from bronchoalveolar lavage fluid from children with suspected chronic lower respiratory tract infection:results from a multi-center,cross-sectional study in Spain[J]. Eur J Pediatr, 2018, 177(2):181-192.
DOI
URL
|
[3] |
NING G, WANG X, WU D, et al. The etiology of community-acquired pneumonia among children under 5 years of age in mainland China,2001-2015:a systematic review[J]. Hum Vaccine Immunother, 2017, 13(11):2742-2750.
DOI
URL
|
[4] |
RODRIGUES C M C, GROVES H. Community-acquired pneumonia in children:the challenges of microbiological diagnosis[J]. J Clin Microbiol, 2018, 56(3):e01318-17.
|
[5] |
MURDOCH D R, MORPETH S C, HAMMITT L L, et al. The diagnostic utility of induced sputum microscopy and culture in childhood pneumonia[J]. Clin Infect Dis, 2017, 64(Suppl 3):S280-S288.
|
[6] |
POPOVA G, BOSKOVSKA K, ARNAUDOVA-DANEVSKA I, et al. Sputum quality assessment regarding sputum culture for diagnosing lower respiratory tract infections in children[J]. Open Access Maced J Med Sci, 2019, 7(12):1926-1930.
DOI
URL
|
[7] |
CHERRY J D. Epidemic pertussis in 2012-the resurgence of a vaccine-preventable disease[J]. N Engl J Med, 2012, 367(9):785-787.
DOI
URL
|
[8] |
刘莹, 姚开虎. 百日咳再现的研究进展[J]. 中华儿科杂志, 2018, 56(4):313-316.
|
[9] |
中华人民共和国国家健康委员会, 国家中医药局. 儿童社区获得性肺炎诊疗规范(2019年版)[J]. 中华临床感染病杂志, 2019, 12(1):6-13.
|
[10] |
中华医学会儿科学分会感染学组,《中华儿科杂志》编辑委员会. 中国儿童百日咳诊断与治疗建议[J]. 中华儿科杂志, 2017, 55(8):568-572.
|
[11] |
中华医学会儿科学分会感染学组, 中国儿童感染性疾病病原学及细菌耐药监测协作组, 中华儿科杂志编辑委员会. 儿童流感嗜血杆菌感染诊断及治疗专家建议[J]. 中华儿科杂志, 2019, 57(9):663-668.
|
[12] |
SAKWINSKA O, BASTIC SCHMID V, BERGER B, et al. Nasopharyngeal microbiota in healthy children and pneumonia patients[J]. J Clin Microbiol, 2014, 52(5):1590-1594.
DOI
URL
|
[13] |
BERRINGTON J E, CUMMINGS S P, EMBLETON N D. The nasopharyngeal microbiota:an important window of opportunity[J]. Am J Respir Crit Care Med, 2014, 190(3):246-248.
|
[14] |
刘又宁. 浅议痰细菌培养与体外药敏试验结果的临床参考价值与局限性[J]. 中华结核和呼吸杂志, 2012, 35(4):241-242.
|
[15] |
CHONMAITREE T, JENNINGS K, GOLOVKO G, et al. Nasopharyngeal microbiota in infants and changes during viral upper respiratory tract infection and acute otitis media[J]. PLoS One, 2017, 12(7):e0180630.
DOI
URL
|
[16] |
SAKWINSKA O, BASTIC SCHMID V, BERGER B, et al. Nasopharyngeal microbiota in healthy children and pneumonia patients[J]. J Clin Microbiol, 2014, 52(5):1590-1594.
DOI
URL
|
[17] |
宁桂军, 高源, 吴丹, 等. 中国2011-2017年百日咳流行病学特征分析[J]. 中国疫苗和免疫, 2018, 24(3):264-267.
|
[18] |
ESPOSITO S, STEFANELLI P, FRY N K, et al. Pertussis prevention:reasons for resurgence,and differences in the current acellular pertussis vaccines[J]. Front Immunol, 2019, 10:1344.
DOI
URL
|
[19] |
HUA C Z, WANG H J, ZHANG Z, et al. In vitro activity and clinical efficacy of macrolides,cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates:a single-center study in Zhejiang Province,China[J]. J Glob Antimicrob Resist, 2019, 18:47-51.
DOI
URL
|